// App-Quantinova.ai

: Cross-trial comparison of taxane versus non-taxane combination chemotherapy regimens for advanced penile cancer (APC): A systematic review.

Researchers

Presenter

  • Esmail Mutahar Al-Ezzi

Principal Investigators

  • Jamila Jama Almi Riromar

  • Eitan Amir

  • Rouhi Fazelzad

  • Aaron Richard Hansen

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret - University Health Network, Toronto, ON, CA

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Penile carcinoma

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • Carboplatin

  • Paclitaxel

  • Docetaxel

  • Cisplatin

  • taxane

Outcome

  • N/A


Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A